Member Exclusive News

The week in industry: Canada approves its first ever RNAi therapeutic

This week: Orphan Status granted for Muscular Atrophy treatment, The AMR Centre and Shionogi join forces to further develop antiviral treatment and Takeda extends option to develop Humabody therapies.

Jul 25, 2019
0
0

Please sign in or register for FREE

No comments yet.